Masahiro Kanamaru

RIVERFIELD, Inc. engages in the research, development, and manufacture of medical equipment systems. It specializes in the production and commercialization of surgical robotic support systems for the medical and healthcare industries. The firm also offers endoscopic operation systems. The company was founded on May 20, 2014 and is headquartered in Tokyo, Japan.

Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan.

GORYO Chemical, Inc. develops and sells fluorescent probes. It offers Fluorescence imaging, Cancer Targets, in vitro cellular assay, in vivo imaging, cell, Super-Resolution Microscopy, Optical Microscopy, Small Animal Molecular Imaging, Near Infrared Fluorescence, High Content Screening, Molecular Biology and Molecular Diagnostics. The company was founded on July 16, 2010 by Ken-ichi Maruyama and is headquartered in Sapporo, Japan.

orylab, Inc. engages in the development of robots for video calling. Its services include orihime business, licensing business and others. The company was founded by Kentaro Yoshifuji, Aki Yuki and Yoshifumi Shiiba on September 28, 2012 and is headquartered in Mitaka, Japan.

Elephantech Inc. offers conductive markers and printer cartridges with silver conductive ink. It develops and sells DIY kit which converts household printer into electronic circuit printing machine under the name of AgIC print. The company was founded by Shinya Shimizu and Masaaki Sugimoto in 2014 and is headquartered in Tokyo, Japan.

Regional Fish Institute, Ltd. is a Japanese company that focuses on innovation in the aquatic industry through high-speed breeding and smart aquaculture. The company is based in Kyoto, Japan. The company aims to contribute to the industry and create new industries in the region. The company was founded in 2019 by Tadanori Umekawa, Masato Kinoshita. Tadanori Umekawa has been the CEO since 2019.

Novenine, Inc. provides oral healthcare services and offers healthcare management systems. Novenine was founded in 2018 by Akira Takeyama. Akira Takeyama has been the CEO since 2018.

Spiber, Inc. provides research, development, and production of synthetic spider silk. It specializes in the production of artificial spider silk using synthesized genes which persuade bacteria to produce fibroin, a structural protein found in spider silk. The firm analyzes the mechanism of the bimolecular structure of spider silk protein using bioinformatics. The company was founded on September 26, 2007 and is headquartered in Tsuruoka, Japan.

Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming.

Arcline Investment Management LP (Arcline Investment) is a private equity firm founded in 2018 by Rajeev Joseph Amara. The firm is headquartered in San Francisco, California.

California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019.

Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA.

Myoridge KK is a company based in Kyoto, Japan that specializes in selling cell products and developing support services for cell culture. The Japanese company also offers development support services for materials, operating methods, and equipment for all stages of the process. The company was founded in 2016 by Naohiro Makita, Shinichi Sueda.

Metcela, Inc. provides therapies for heart failure treatment. The company was founded by Takahiro Iwamiya and Kenichi Nogami on March 09, 2016 and is headquartered in Kawasaki, Japan.

GlycoMira Therapeutics, Inc. is a preclinical-stage biopharmaceutical company based in Salt Lake City, UT. The private company is dedicated to improving the standard of care and outcomes for patients with cancer and other inflammatory diseases. GlycoMira is developing a new class of innate immune system modulators based on polysaccharides that naturally occur within the body. The company's lead drug candidate, GM-1111, has demonstrated potential to address unmet needs in solid tumor treatment and supportive care. The CEO of the company is William P. Tew.

Iviva Medical, Inc. develops autologous tissue to serve kidney diseases. The company was founded by Harald C Ott and is headquartered in Beverly, MA.

Keio Innovation Initiative, Inc. (Keio Innovation Initiative) is the venture capital arm of Keio Academic Enterprise Co. Ltd. and is headquartered in Tokyo, Japan. The firm was founded in 2015 by Keio University.